JP2013508279A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508279A5
JP2013508279A5 JP2012534259A JP2012534259A JP2013508279A5 JP 2013508279 A5 JP2013508279 A5 JP 2013508279A5 JP 2012534259 A JP2012534259 A JP 2012534259A JP 2012534259 A JP2012534259 A JP 2012534259A JP 2013508279 A5 JP2013508279 A5 JP 2013508279A5
Authority
JP
Japan
Prior art keywords
compound
group
salt
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012534259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/052126 external-priority patent/WO2011046851A1/en
Publication of JP2013508279A publication Critical patent/JP2013508279A/ja
Publication of JP2013508279A5 publication Critical patent/JP2013508279A5/ja
Withdrawn legal-status Critical Current

Links

JP2012534259A 2009-10-15 2010-10-11 スピロピペリジン化合物および糖尿病治療のためのその医薬用途 Withdrawn JP2013508279A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25183909P 2009-10-15 2009-10-15
US61/251,839 2009-10-15
US30333410P 2010-02-11 2010-02-11
US61/303,334 2010-02-11
PCT/US2010/052126 WO2011046851A1 (en) 2009-10-15 2010-10-11 Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes

Publications (2)

Publication Number Publication Date
JP2013508279A JP2013508279A (ja) 2013-03-07
JP2013508279A5 true JP2013508279A5 (US07846941-20101207-C00217.png) 2013-11-07

Family

ID=43719548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012534259A Withdrawn JP2013508279A (ja) 2009-10-15 2010-10-11 スピロピペリジン化合物および糖尿病治療のためのその医薬用途

Country Status (24)

Country Link
US (1) US8383642B2 (US07846941-20101207-C00217.png)
EP (1) EP2488500A1 (US07846941-20101207-C00217.png)
JP (1) JP2013508279A (US07846941-20101207-C00217.png)
KR (1) KR20120051777A (US07846941-20101207-C00217.png)
CN (1) CN102574807A (US07846941-20101207-C00217.png)
AR (1) AR078522A1 (US07846941-20101207-C00217.png)
AU (1) AU2010307094A1 (US07846941-20101207-C00217.png)
BR (1) BR112012008889A2 (US07846941-20101207-C00217.png)
CA (1) CA2777775A1 (US07846941-20101207-C00217.png)
CL (1) CL2012000921A1 (US07846941-20101207-C00217.png)
CO (1) CO6531458A2 (US07846941-20101207-C00217.png)
CR (1) CR20120177A (US07846941-20101207-C00217.png)
DO (1) DOP2012000105A (US07846941-20101207-C00217.png)
EA (1) EA201270560A1 (US07846941-20101207-C00217.png)
EC (1) ECSP12011799A (US07846941-20101207-C00217.png)
IL (1) IL218344A0 (US07846941-20101207-C00217.png)
MA (1) MA33662B1 (US07846941-20101207-C00217.png)
MX (1) MX2012004420A (US07846941-20101207-C00217.png)
NZ (1) NZ598972A (US07846941-20101207-C00217.png)
PE (1) PE20121437A1 (US07846941-20101207-C00217.png)
TN (1) TN2012000152A1 (US07846941-20101207-C00217.png)
TW (1) TW201124415A (US07846941-20101207-C00217.png)
WO (1) WO2011046851A1 (US07846941-20101207-C00217.png)
ZA (1) ZA201202560B (US07846941-20101207-C00217.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2456515T3 (es) 2009-03-23 2014-04-22 Glenmark Pharmaceuticals S.A. Derivados de pirimidindiona fusionados como moduladores de TRPA1
PT2411395E (pt) 2009-03-23 2013-06-06 Glenmark Pharmaceuticals Sa Derivados de furopirimidinadiona como moduladores de trpa1
AR078948A1 (es) 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes
NZ601408A (en) 2009-12-25 2013-12-20 Mochida Pharm Co Ltd Novel 3-hydroxy-5-arylisothiazole derivative
WO2012046869A1 (ja) 2010-10-08 2012-04-12 持田製薬株式会社 環状アミド誘導体
CA2829351A1 (en) 2011-03-11 2012-09-20 Intercontinental Great Brands Llc System and method of forming multilayer confectionery
JP5420796B2 (ja) 2011-04-27 2014-02-19 持田製薬株式会社 新規3−ヒドロキシイソチアゾール1−オキシド誘導体
JPWO2012147516A1 (ja) 2011-04-28 2014-07-28 持田製薬株式会社 環状アミド誘導体
AR087451A1 (es) 2011-08-17 2014-03-26 Lilly Co Eli Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes
WO2013139341A1 (en) * 2012-03-20 2013-09-26 Syddansk Universitet Gpr120 receptor modulators
WO2013185766A1 (en) * 2012-06-15 2013-12-19 Syddansk Universitet Gpr120 receptor modulators
CN104812748B (zh) 2012-11-16 2017-10-24 百时美施贵宝公司 二氢吡唑gpr40调节剂
KR101569522B1 (ko) * 2013-04-18 2015-11-17 현대약품 주식회사 신규한 3-(4-(벤질옥시)페닐)헥스-4-이노익 산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물
CN105722841A (zh) * 2013-11-14 2016-06-29 卡迪拉保健有限公司 新型杂环化合物
US20150351889A1 (en) 2014-06-05 2015-12-10 Vivex Biomedical Inc. Dynamic Biometric Mesh
CA2960944C (en) * 2014-10-17 2019-09-10 Hyundai Pharm Co., Ltd. Use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivatives in combination with a secondary active ingredient for the treatment of metabolic diseases
CN109666027A (zh) * 2017-10-17 2019-04-23 中国科学院上海药物研究所 一类酰胺结构的gpr40激动剂化合物及其用途
DK3737470T5 (da) 2018-01-08 2024-05-27 Celon Pharma Sa 3-phenyl-4-hexynsyrederivater som gpr40-agonister
SG11202007646UA (en) 2018-02-13 2020-09-29 Gilead Sciences Inc Pd-1/pd-l1 inhibitors
TWI712412B (zh) 2018-04-19 2020-12-11 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
TWI732245B (zh) 2018-07-13 2021-07-01 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
CN112955435A (zh) 2018-10-24 2021-06-11 吉利德科学公司 Pd-1/pd-l1抑制剂
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119
BR112022023359A2 (pt) 2020-05-19 2023-04-18 Kallyope Inc Ativadores de ampk
EP4172162A1 (en) 2020-06-26 2023-05-03 Kallyope, Inc. Ampk activators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316559T3 (es) * 2001-04-18 2009-04-16 Euro-Celtique S.A. Compuestos espiroindeno y espiroindano.
RU2005134230A (ru) * 2003-04-04 2006-05-10 Мерк энд Ко., Инк. (US) Ацилированные производные спиропиперидина как агонисты рецептора меланокортина-4
CA2544602A1 (en) * 2003-11-04 2005-05-26 Elixir Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
WO2005051890A1 (en) 2003-11-19 2005-06-09 Smithkline Beecham Corporation Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40
KR20070004769A (ko) 2004-02-27 2007-01-09 암젠 인코포레이션 대사 장애의 치료에 사용되는 화합물, 약제학적 조성물 및그 사용방법
WO2005095338A1 (ja) * 2004-03-30 2005-10-13 Takeda Pharmaceutical Company Limited アルコキシフェニルプロパン酸誘導体
CA2621949A1 (en) * 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
CA2662242C (en) 2006-09-07 2012-06-12 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
NZ584161A (en) 2007-10-26 2011-12-22 Japan Tobacco Inc Spiro-ring compound and use thereof for medical purposes
CA2706391A1 (en) * 2007-11-21 2009-05-28 Janssen Pharmaceutica N.V. Spiropiperidines for use as tryptase inhibitors
AR078948A1 (es) 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes

Similar Documents

Publication Publication Date Title
JP2013508279A5 (US07846941-20101207-C00217.png)
JP2013512277A5 (US07846941-20101207-C00217.png)
JP2013518107A5 (US07846941-20101207-C00217.png)
JP2012525393A5 (US07846941-20101207-C00217.png)
JP2013542247A5 (US07846941-20101207-C00217.png)
JP2009535307A5 (US07846941-20101207-C00217.png)
JP2010077141A5 (US07846941-20101207-C00217.png)
JP2016530259A5 (US07846941-20101207-C00217.png)
JP2014511891A5 (US07846941-20101207-C00217.png)
JP2013537203A5 (US07846941-20101207-C00217.png)
JP2013510120A5 (US07846941-20101207-C00217.png)
JP2012505836A5 (US07846941-20101207-C00217.png)
JP2009535352A5 (US07846941-20101207-C00217.png)
JP2013509429A5 (US07846941-20101207-C00217.png)
JP2011504903A5 (US07846941-20101207-C00217.png)
JP2009523760A5 (US07846941-20101207-C00217.png)
JP2011528713A5 (US07846941-20101207-C00217.png)
JP2020507589A5 (US07846941-20101207-C00217.png)
JP2013507439A5 (US07846941-20101207-C00217.png)
JP2009504763A5 (US07846941-20101207-C00217.png)
JP2014505107A5 (US07846941-20101207-C00217.png)
JP2014518266A5 (US07846941-20101207-C00217.png)
JP2014508804A5 (US07846941-20101207-C00217.png)
JP2007302689A5 (US07846941-20101207-C00217.png)
JP2011246469A5 (US07846941-20101207-C00217.png)